Evidence map›Paper›PMID 36495412›Full record

ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2023

Efficacy and safety of zero-fluoroscopy approach for ablation of atrioventricular nodal reentry tachycardia: experience from more than 1000 cases.

Aleksandra Świętoniowska-Mścisz, Piotr Stec, Sebastian Stec, Lesław Szydłowski, Magdalena Zagrodzka, Jacek Kusa, Aleksandra Morka, Tomasz Kameczura, Adrian Mścisz, Anna Stec-Gola and 2 more

Open access · greenAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Intracardiac echocardiography and electroanatomical mapping: do we still need fluoroscopy for cardioneuroablation procedures?Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Aleksandra Świętoniowska-MściszSubcarpathian Regional Hospital, Krosno, Poland. a.swietoniowska@gmail.com.ORCID http://orcid.org/0000-0002-8980-1255
Piotr StecDepartment of Cardiology, Regional Specialist Hospital, Stalowa Wola, Poland.
Sebastian StecELMedica, EP-Network, SKA, Poland.
Lesław SzydłowskiDepartment of Pediatric Cardiology, Faculty of Medical Sciences, Medical University of Silesia, Katowice, Poland.
Magdalena ZagrodzkaQUADIA Diagnostic Centre, Piaseczno, Poland.
Jacek KusaDepartment of Pediatric Cardiology, Medical University of Silesia, Katowice, Poland.
Aleksandra MorkaFaculty of Health Sciences, Jagiellonian University Medical College, Department of Pediatric Cardiac Surgery, Children's University Hospital, Krakow, Poland.
Tomasz KameczuraChair of Electrocardiology, Faculty of Medicine, University of Rzeszow, Rzeszow, Poland.
Adrian MściszMedologic - Medical technology platform, Regional Development Agency, Rzeszów, Poland.
Anna Stec-GolaDepartment of Valvular Heart Disease, National Institute of Cardiology, Warsaw, Poland.
Dariusz KarbarzDepartment of Cardiology, MSZS, Radom, Poland.
Janusz ŚledźELMedica, EP-Network, SKA, Poland.
Medical University of Silesia · PLInstitute of Cardiology · PLJagiellonian University · PLRadom College · PLRzeszów University of Technology · PLState Higher Vocational School in Krosno · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRadiofrequency catheter ablation (RFCA) of the slow pathway in atrioventricular nodal reentry tachycardia (AVNRT) is associated with high efficacy and low risk of total perioperative or late atrioventricular block. This study aimed to evaluate the efficacy, safety, and feasibility of slow-pathway RFCA for AVNRT using a zero-fluoroscopy approach.

methodsData were obtained from a prospective multicenter registry of catheter ablation from January 2012 to February 2018. Consecutive unselected patients with the final diagnosis of AVNRT were recruited. Electrophysiological and 3-dimensional (3D) electroanatomical mapping systems were used to create 3D maps and to navigate only 2 catheters from the femoral access. Acute procedural efficacy was evaluated using the isoproterenol and/or atropine test, with 15-min observation after ablation. Each case of recurrence or complication was consulted at an outpatient clinic during long-term follow-up.

resultsOf the 1032 procedures, 1007 (97.5%) were completed without fluoroscopy. Conversion to fluoroscopy was required in 25 patients (2.5%), mainly due to an atypical location of the coronary sinus (n = 7) and catheter instability (n = 7). The mean radiation exposure time was 1.95 ± 1.3 min for these cases. The mean fluoroscopy time for the entire study cohort was 0.05 ± 0.4 min. The mean total procedure time was 44.8 ± 18.6 min. There were no significant in-hospital complications. The total success rate was 96.1% (n = 992), and the recurrence rate was 3.9% (n = 40).

conclusionSlow-pathway RFCA can be safely performed without fluoroscopy, with a minimal risk of complications and a high success rate.

Indexed as

Atrioventricular BlockCatheter AblationTachycardia, Atrioventricular Nodal ReentryFluoroscopyHumansIsoproterenolProspective StudiesTreatment OutcomeIsoproterenolAblationAtrioventricular nodal reentry tachycardiaElectroanatomical mappingRadiation exposureZero-fluoroscopy approach

Identifiers

PMID36495412
OpenAlexW4311021217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.